Is 2.5 mg/mL a sensible working concentration for oral semaglutide, or should I go lower?

The case in front of me: 2.5 mg/mL · oral semaglutide.

I would like the axes of comparison first and the recommendation second.

I have tried the first option and it works; the question is whether the second is better rather than merely different.

Under what conditions does the answer flip?

Mechanically, this is the one decision in the whole preparation sequence that cannot be revised later, which is why it is worth thirty seconds of arithmetic.

Vial headspace is the hard constraint. A nominal 2 mL vial typically holds a little over 2 mL to the shoulder; adding 3 mL is not an option and attempting it wastes the lot.

Worked example. A 10 mg vial reconstituted with 2 mL gives 5 mg/mL. A 0.5 mg dose is 0.5 ÷ 5 = 0.1 mL, which on a U-100 syringe is 10 units. Reconstitute the same vial with 1 mL and the concentration doubles to 10 mg/mL, the same dose becomes 0.05 mL, and you are now reading 5 units instead of 10 — the same dose at half the resolution.

U-100 means 100 units per millilitre by definition, so 1 unit is 0.01 mL and volume in millilitres times one hundred gives units. Every conversion here reduces to that.

A concentration calculated to three decimal places from a diluent volume measured to one is false precision.

Choose the volume that puts your largest intended dose between 10 and 30 units. Everything else follows.

Answer first: diluent volume sets concentration and therefore resolution on the syringe barrel, and resolution is free at reconstitution and impossible to recover afterwards.

For a dose that will change during titration, choose the volume for the largest intended dose rather than the first, so the whole schedule fits on one barrel without a mid-vial recalculation.

Write the concentration and the resulting units-per-dose on the vial label at reconstitution. The arithmetic that is obvious now will not be obvious at six in the morning three weeks from now.

Do not change the diluent volume between vials of a titration without recalculating; it is the commonest source of a ten-fold error.

Concentration equals content over volume, and content is not label claim.

The short version: more diluent means a lower concentration, a larger volume per dose and a finer reading; less means the opposite.

Content matters. If the same 10 mg vial assays at 94 per cent content, you have 9.4 mg. In 2 mL that is 4.7 mg/mL, and a nominal 0.5 mg draw of 10 units actually delivers 0.47 mg — a six per cent shortfall that no amount of careful drawing will fix.

Nominal vial volumes in the standard 2R and 3R glass sizes have published brimful capacities well above the nominal fill, but the usable volume is bounded by the stopper displacement.

Measure a volume you can actually measure. Round numbers, real syringes.

Aim for a dose volume somewhere between about 10 and 30 units on a U-100 barrel and the reading problem disappears.

Dead-space loss scales with the number of draws, not with the concentration, so a lower concentration spread over more draws loses proportionally less of the total peptide.

Nothing here is medical advice, and research-use material is not approved for human use.

Check the vial can physically hold the volume before you draw it up.